A Closer Look Into the Role of Compounding Pharmacies
Donald Prentiss discusses the value of these pharmacies, especially during shortages.
In this exclusive PC Podcast interview, Donald Prentiss, founder and CEO of Qualthera, explains:
- The role that compounding pharmacies play in the pharmaceutical supply chain
- How compounding pharmacies helped bridge the gap for patients in need of their medication (especially during the tirzepatide shortage), while dispelling the notion that commercialized and compounded drugs are competing with one another.
- What he believes needs to be done amid the various legal battles pertaining to GLP-1s that are currently taking place
- The inspiration behind Qualthera, along with its objectives
The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.
Recent Videos
Related Content
The Biosimilars Landscape Through the Eyes of an Economist
February 21st 2025Article
James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.
